Useful Links :
Why Publish with us :
- » Open Access Policy
- » Flexible Online Submission
- » Preliminary Quality Report within 3 days
- » 21 days Rapid Peer-Review
- » High Quality Publication
- » Global Promotion
- » Responsive Editorial Staff
- » Globally Recognized Journals
- » 24/7 Editorial Office Availability
Advances in Hematology and Blood Disorders is a peer-reviewed, open-access journal that mainly deals with the study of hematology and blood research. It focuses on all aspects of hematology including blood cells, hematologic diseases, blood hemostatic mechanisms, hemato-oncology, immunology, and transfusion medicine. It also focuses on all aspects of the prevention and therapy of blood disorders.
The Journal publishes recent discoveries and current developments in the mode of original articles, review articles, case reports, short communications, editorials, etc. in all areas of the Hematology and Blood Research field.
We also welcome case reports from all areas of hematology including hematologic oncology, hemobiology, vascular biology, hemophilia, Blood and Marrow transplantation, Blood Transfusion, Blood Clots, Lymphatic System, Anemia, Platelet disorders, Eosinophilic disorders, Leukemia, Myeloma, Coagulation disorders, Autoimmune blood cell disorders, Blood cancers, Myeloproliferative neoplasms, Clinical platelet disorders, White blood cell disorders, etc.
No Profit-Oriented Goal Setting, No Hidden Clues
We believe a manuscript is the ultimate form of contribution of a researcher for the betterment of the global community. Impactful researches should be available to global readers with no hindrance. We never claim Publication Fees beyond the limit of the researchers.
The initial manuscript handling persons are Editorial Board Members. The decision from them will be communicated to Editor-in-Chief/Managing Editor. If assertive comments from all ends, the manuscript will go for rigorous peer-review. In all the cases stated above, only the recognized experts in the respective field will be allowed to comment on the manuscript.
The single manuscript will be assigned to multiple reviewers and the most logical and elaborated comments will be accepted for evaluation. In no condition, peer-review process will be extended more than 14 days.
Managing Editor’s Role
Managing Editor's will follow up and provide adequate responses regarding the manuscript assigned to him/her. Managing Editor’s will not interfere in the decision-making process of the manuscript. In a critical situation, the managing editor will assign the manuscript to the additional reviewer in case the review process is delayed or lack of communication with the reviewer.
Rapid and Fast Publication
All segments of the manuscript processing-related communications are transparent, rapid, and effortless which in other way helps to complete the article processing within the promised timeline.